The vector of anti-CLL-1 chimeric antigen receptor (CAR) is based on the FcεRI receptor scaffold and constructed for the engineering of T cells to target human CLL-1. The T cells are genetically modified through transduction with a lentiviral vector expressing an alpha chain comprising a scFv of anti-CLL-1 antibody linked to FcεR1γ-SP and FcεR1γ-TM-IC, a beta chain comprising FcεR1γ-ΔITAM linked to CD28 signaling domain, a gamma chain comprising FcεR1γ-SP-ΔITAM linked to CD3ζ signaling domain. And the vector product was designed for the treatment of acute lymphoblastic leukemia.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-MZ002||Anti-CLEC12A (Clone M26) h(CTLA4-CD3ζ) CAR, pCDCAR1|
|CAR-LC312||Anti-CLEC12A (SC02-357) h(41BB/CD3ζ) Multi-chain CAR, pCDCAR1|
|VP-CAR-LC737||Lenti-CLEC12A CAR (scFv-CTLA4-CD3ζ, Clone M26) Viral Particle|
|CAR-LC324||Anti-CLEC12A (M22) h(41BB/CD3ζ) Multi-chain CAR, pCDCAR1|
|CAR-LC335||Anti-CLEC12A (21.26) h(CD28/CD3ζ) Multi-chain CAR, pCDCAR1|
|VP-CAR-LC523||Lenti-CLEC12A CAR (scFv-41BB-CD3ζ) Viral Particle|
|CAR-LC329||Anti-CLEC12A (M2) h(CD28/CD3ζ) Multi-chain CAR, pCDCAR1|
|CAR-LC315||Anti-CLEC12A (SC02-378) h(CD28/CD3ζ) Multi-chain CAR, pCDCAR1|
|CAR-LC313||Anti-CLEC12A (SC02-357) h(CD28/CD3ζ) Multi-chain CAR, pCDCAR1|
|CAR-LC017||Anti-CLL-1 h(41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved